Clinical Trial Detail

NCT ID NCT01619813
Title Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Indications

prostate adenocarcinoma

Therapies

Docetaxel + Prednisone

Pelareorep

Age Groups: adult

No variant requirements are available.